Monday, March 30, 2026
News Health

News Health

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain. Medscape Medical News Source link : https://www.medscape.com/viewarticle/enfortumab-vedotin-pembro-beats-cisplatin-resectable-mibc-2026a10006gl?src=rss...

Read more
Page 56 of 168 1 55 56 57 168

Categories

Archives

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031